Stock Market News for July 2, 2026

Automotive, EVs and production updates

Tesla (TSLA) published its Q2 2026 production and delivery figures today. Investors will parse volumes for demand signals and margin pressure as Tesla manages pricing, inventory and capex decisions.

Rivian (RIVN) released Q2 production and delivery figures and raised its full-year delivery outlook, signaling easing demand concerns if production efficiency and cost control hold: company release.

Lucid (LCID) announced Q2 production and deliveries and outlined leadership changes aimed at tightening execution—key for any turnaround and order‑book momentum: details.

Faraday Future (FFAI) plans a special meeting on Aug. 12 to seek shareholder approval for key proposals tied to its FF EAI Robot World execution—a governance step that could accelerate strategic shifts if passed.

Biotech: approvals, clinical milestones and takeovers

HUTCHMED (HCM) won NMPA approval for ORPATHYS® in MET‑amplified gastric cancer, a commercial foothold in China oncology: announcement.

Myriad Genetics (MYGN) published a large meta-analysis showing strong prognostic performance for Prolaris®, which could support wider clinical adoption and payer coverage: study note.

BridgeBio (BBIO) reported that acoramidis shows early, sustained kidney‑protective effects in ATTR‑CM—if confirmed, this could expand clinical value and market potential: study note.

Seer (SEER) disclosed receipt of an unsolicited acquisition proposal from Omid Farokhzad, M.D. — a development that can trigger strategic reviews, shareholder debate and potential premium bids.

Energy, mining and critical minerals

Cameco (CCJ) closed a deal to increase ownership in the Cigar Lake mine, strengthening control over uranium production amid enduring nuclear demand themes: transaction note.

Hudbay (HBM) received regulatory approval to increase mill throughput at Constancia in Peru, supporting higher copper output and potential revenue upside: company release.

Pembina Pipeline (PBA) announced a positive final investment decision on the Greenlight Electricity Centre, highlighting midstream diversification into electrification.

Ero Copper (ERO) will release Q2 operating and financial results on Aug. 5, a date investors will watch for metal production and cost trends.

Corporate updates, earnings and governance

Kinross (KGC) set an August date to report Q2 results on July 29, keeping miners' earnings cadence active for commodity‑sensitive portfolios.

Lindsay Corporation (LNN) reported fiscal Q3 2026 results; investors are watching margins and backlog for signs of agricultural and infrastructure demand: earnings release.

Baidu (BIDU) set a record date for an extraordinary general meeting, a governance step that often precedes strategic votes or reorganization plans: notice.

Bank7 Corp. (BSVN) agreed to acquire a controlling interest in Century Financial Services, a regional consolidation move that can expand lending scale and fee income: deal note.

Tech, security and enterprise software

Fortinet (FTNT) set a date to report Q2 financial results. Cybersecurity metrics remain central to recurring revenue and cloud upsell visibility.

Dynatrace (DT) intends to pursue FedRAMP High, potentially unlocking larger federal contracts and boosting long‑term SaaS revenue clarity.

VivoPower (VIVO) reinforced its focus on the AI data‑center business and provided updates on non‑core assets, signaling a strategic tilt toward higher‑growth infrastructure exposure.

M&A, divestitures and strategic deals

Zoom (ZM) agreed to buy Common Room, an inorganic push to accelerate enterprise AI monetization and buyer-intelligence features.

Avanos Medical (AVNS) and American Industrial Partners received regulatory approvals for their pending merger, clearing a key milestone toward closing: regulatory notice.

Standex (SXI) acquired the remaining interest in Narayan Powertech, simplifying governance and potentially improving margin capture in specialty industrials: transaction note.

Listings, indexes and market structure

IQM Quantum Computers (IQMX) became the first European quantum hardware company listed on a major U.S. exchange and will also list on Nasdaq Helsinki, widening capital access for quantum startups: listing note.

Cingulate Inc. (CING) was added to the Russell 3000E®, a change likely to attract passive flows and boost near‑term liquidity: notice.

Centrus Energy and Midera Food Processing are set to join the S&P SmallCap 600, moves that typically draw index tracking flows and lift liquidity for affected names.

Payments, crypto and capital markets moves

Hyperscale Data (GPUS) added 67 BTC to its treasury for a total near 849 Bitcoin, tying part of the balance sheet to crypto price swings: details.

Peraso (PRSO) entered into a committed equity facility up to $25M, providing optionality to fund execution without immediate dilution pressure.

Securitize (SECZ) tokenized its public stock onchain at listing day, an experiment in tokenized securities that could influence future capital‑raising mechanics: announcement.

Med‑tech, devices and regulatory clearances

Tenon Medical (TNON) received FDA 510(k) clearance for the Catamaran® SI Joint Fusion System, a clearance that can accelerate commercial uptake: clearance notice.

Butterfly Network (BFLY) expanded handheld ultrasound availability into Brazil, opening a large market for device and software revenue growth: announcement.

Defense and specialized tech

Kratos (KTOS) received an approximate $36M air‑defense system single‑award contract, providing predictable near‑term revenue: contract notice.

Smaller but watch‑list items

• Abivax (ABVX) saw underwriters fully exercise an offering option, bringing gross proceeds to $920M (€807M), materially extending runway for late‑stage programs: offering details.
• Myriad Genetics (MYGN)'s meta‑analysis on Prolaris® (see above) remains a clinical adoption story investors should track for payer coverage trends.
• Alarum Technologies (ALAR) responded to an inquiry into residential proxy networks, a regulatory‑style update investors will watch for compliance and reputation risk.